Chen Xue
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in
-
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 5
- Hepatology 11
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Co-authors
- Lanjuan Li (20 shared papers)Ganglei Li (7 shared papers)Juan Lü (5 shared papers)Xinyu Gu (15 shared papers)Zhengyi Bao (9 shared papers)Yalei Zhao (5 shared papers)Qiuxian Zheng (6 shared papers)Yuanshuai Su (7 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (4 papers)International Journal of Molecular Sciences (3 papers)Biomedicine & Pharmacotherapy (3 papers)Frontiers in Oncology (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Chen Xue
125 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 546
- Clinical Biochemistry 164
- Molecular Biology 1.2k
- Hepatology 130
- Aging 17
Countries citing papers authored by Chen Xue
This map shows the geographic impact of Chen Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Xue more than expected).
Fields of papers citing papers by Chen Xue
This network shows the impact of papers produced by Chen Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Xue. The network helps show where Chen Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 163 | |
| 2 | 2021 | 159 | |
| 3 | 2022 | 149 | |
| 4 | 2021 | 117 | |
| 5 | 2020 | 104 | |
| 6 | 2022 | 103 | |
| 7 | 2014 | 97 | |
| 8 | 2018 | 74 | |
| 9 | 2024 | 74 | |
| 10 | 2010 | 72 | |
| 11 | 2007 | 67 | |
| 12 | 2018 | 67 | |
| 13 | 2020 | 65 | |
| 14 | 2020 | 61 | |
| 15 | 2023 | 61 | |
| 16 | 2016 | 57 | |
| 17 | 2018 | 51 | |
| 18 | 2015 | 50 | |
| 19 | 2019 | 48 | |
| 20 | 2006 | 47 |
About Chen Xue
Chen Xue is a scholar working on Cancer Research, Hepatology, Molecular Biology, Oncology and Biotechnology, having authored 130 papers that have together received 3.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), MicroRNA in disease regulation (5 papers), Gut microbiota and health (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Cancer Research (546 citations), Clinical Biochemistry (164 citations), Molecular Biology (1.2k citations), Hepatology (130 citations) and Aging (17 citations). Chen Xue has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Lanjuan Li, Ganglei Li, Juan Lü, Xinyu Gu, Zhengyi Bao, Yalei Zhao, Qiuxian Zheng, Yuanshuai Su, Qingmiao Shi and Weijing Cai. Their work appears in journals such as Signal Transduction and Targeted Therapy, International Journal of Molecular Sciences, Biomedicine & Pharmacotherapy, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.